Видео ютуба по тегу Cll8 Trial

Dr. O'Brien Discusses the Standard of Care for CLL
Dr. O'Brien Discusses the Standard of Care for CLL
FCR or FR – which regimen is better for treating CLL?
FCR or FR – which regimen is better for treating CLL?
Exciting Clinical Trials for CLL in 2025
Exciting Clinical Trials for CLL in 2025
The SOUNDTRACK-E trial: investigating AZD0486 in CLL, MCL, and DLBCL
The SOUNDTRACK-E trial: investigating AZD0486 in CLL, MCL, and DLBCL
CLL Clinical Trials
CLL Clinical Trials
CLL Clinical Trials Explained
CLL Clinical Trials Explained
The BRUIN CLL-313 trial: pirtobrutinib versus BR in previously untreated CLL
The BRUIN CLL-313 trial: pirtobrutinib versus BR in previously untreated CLL
Case report: the continued efficacy of low-dose ibrutinib for CLL after 10 years of treatment
Case report: the continued efficacy of low-dose ibrutinib for CLL after 10 years of treatment
Acalabrutinib and Obinutuzumab for Frontline CLL Treatment
Acalabrutinib and Obinutuzumab for Frontline CLL Treatment
Primary findings from the EPCORE CLL-1 trial of epcoritamab in CLL and RT
Primary findings from the EPCORE CLL-1 trial of epcoritamab in CLL and RT
CLL11 trial: tackling tough-to-treat CLL patients with co-morbidities
CLL11 trial: tackling tough-to-treat CLL patients with co-morbidities
Clinical trials of non-chemotherapy-containing therapies by the German CLL Study Group
Clinical trials of non-chemotherapy-containing therapies by the German CLL Study Group
The shift toward fixed-duration combinations in the treatment of CLL
The shift toward fixed-duration combinations in the treatment of CLL
Updates from current CLL clinical trials
Updates from current CLL clinical trials
Is a Clinical Trial Right for You?
Is a Clinical Trial Right for You?
CLL Treatment Advances
CLL Treatment Advances
2022 New + Emerging Treatments: Chronic Lymphocytic Leukemia
2022 New + Emerging Treatments: Chronic Lymphocytic Leukemia
The potential role of therapies targeting surface antigens in the CLL treatment landscape
The potential role of therapies targeting surface antigens in the CLL treatment landscape
How have clinical trials changed in chronic lymphocytic leukemia?
How have clinical trials changed in chronic lymphocytic leukemia?
Rewriting the Script in CLL With Modern Targeted and Next-Gen Options
Rewriting the Script in CLL With Modern Targeted and Next-Gen Options
Redefining endpoints in CLL clinical trials
Redefining endpoints in CLL clinical trials
Overview of Chronic Lymphocytic Leukemia (CLL)
Overview of Chronic Lymphocytic Leukemia (CLL)
Epcore CLL-1: Phase I trial of epcoritamab in r/r CLL
Epcore CLL-1: Phase I trial of epcoritamab in r/r CLL
The tests that are needed to make a definitive diagnosis of CLL
The tests that are needed to make a definitive diagnosis of CLL
New frontiers and emerging treatments for CLL
New frontiers and emerging treatments for CLL